629 related articles for article (PubMed ID: 20564614)
41. Mechanisms of unintended amino acid sequence changes in recombinant monoclonal antibodies expressed in Chinese Hamster Ovary (CHO) cells.
Guo D; Gao A; Michels DA; Feeney L; Eng M; Chan B; Laird MW; Zhang B; Yu XC; Joly J; Snedecor B; Shen A
Biotechnol Bioeng; 2010 Sep; 107(1):163-71. PubMed ID: 20506532
[TBL] [Abstract][Full Text] [Related]
42. IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides.
Niwa R; Natsume A; Uehara A; Wakitani M; Iida S; Uchida K; Satoh M; Shitara K
J Immunol Methods; 2005 Nov; 306(1-2):151-60. PubMed ID: 16219319
[TBL] [Abstract][Full Text] [Related]
43. Fucose removal from complex-type oligosaccharide enhances the antibody-dependent cellular cytotoxicity of single-gene-encoded antibody comprising a single-chain antibody linked the antibody constant region.
Natsume A; Wakitani M; Yamane-Ohnuki N; Shoji-Hosaka E; Niwa R; Uchida K; Satoh M; Shitara K
J Immunol Methods; 2005 Nov; 306(1-2):93-103. PubMed ID: 16236307
[TBL] [Abstract][Full Text] [Related]
44. Producing defucosylated antibodies with enhanced in vitro antibody-dependent cellular cytotoxicity via
Zong H; Han L; Ding K; Wang J; Sun T; Zhang X; Cagliero C; Jiang H; Xie Y; Xu J; Zhang B; Zhu J
Eng Life Sci; 2017 Jul; 17(7):801-808. PubMed ID: 32624826
[TBL] [Abstract][Full Text] [Related]
45. Modulation of therapeutic antibody effector functions by glycosylation engineering: influence of Golgi enzyme localization domain and co-expression of heterologous beta1, 4-N-acetylglucosaminyltransferase III and Golgi alpha-mannosidase II.
Ferrara C; Brünker P; Suter T; Moser S; Püntener U; Umaña P
Biotechnol Bioeng; 2006 Apr; 93(5):851-61. PubMed ID: 16435400
[TBL] [Abstract][Full Text] [Related]
46. Design and testing of zinc finger nucleases for use in mammalian cells.
Porteus M
Methods Mol Biol; 2008; 435():47-61. PubMed ID: 18370067
[TBL] [Abstract][Full Text] [Related]
47. Protein-free transfection of CHO host cells with an IgG-fusion protein: selection and characterization of stable high producers and comparison to conventionally transfected clones.
Lattenmayer C; Loeschel M; Schriebl K; Steinfellner W; Sterovsky T; Trummer E; Vorauer-Uhl K; Müller D; Katinger H; Kunert R
Biotechnol Bioeng; 2007 Apr; 96(6):1118-26. PubMed ID: 17004273
[TBL] [Abstract][Full Text] [Related]
48. Derivation and characterization of cholesterol-independent non-GS NS0 cell lines for production of recombinant antibodies.
Hartman TE; Sar N; Genereux K; Barritt DS; He Y; Burky JE; Wesson MC; Tso JY; Tsurushita N; Zhou W; Sauer PW
Biotechnol Bioeng; 2007 Feb; 96(2):294-306. PubMed ID: 16897745
[TBL] [Abstract][Full Text] [Related]
49. Mcl-1 overexpression leads to higher viabilities and increased production of humanized monoclonal antibody in Chinese hamster ovary cells.
Majors BS; Betenbaugh MJ; Pederson NE; Chiang GG
Biotechnol Prog; 2009; 25(4):1161-8. PubMed ID: 19551877
[TBL] [Abstract][Full Text] [Related]
50. Generation of FX
Liu W; Padmashali R; Monzon OQ; Lundberg D; Jin S; Dwyer B; Lee YJ; Korde A; Park S; Pan C; Zhang B
Biotechnol Prog; 2021 Jan; 37(1):e3061. PubMed ID: 32748555
[TBL] [Abstract][Full Text] [Related]
51. Expression of GnTIII in a recombinant anti-CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FC gamma RIII.
Davies J; Jiang L; Pan LZ; LaBarre MJ; Anderson D; Reff M
Biotechnol Bioeng; 2001 Aug; 74(4):288-94. PubMed ID: 11410853
[TBL] [Abstract][Full Text] [Related]
52. Appropriate mammalian expression systems for biopharmaceuticals.
Werner RG; Noé W; Kopp K; Schlüter M
Arzneimittelforschung; 1998 Aug; 48(8):870-80. PubMed ID: 9748718
[TBL] [Abstract][Full Text] [Related]
53. Loss of core fucosylation of low-density lipoprotein receptor-related protein-1 impairs its function, leading to the upregulation of serum levels of insulin-like growth factor-binding protein 3 in Fut8-/- mice.
Lee SH; Takahashi M; Honke K; Miyoshi E; Osumi D; Sakiyama H; Ekuni A; Wang X; Inoue S; Gu J; Kadomatsu K; Taniguchi N
J Biochem; 2006 Mar; 139(3):391-8. PubMed ID: 16567404
[TBL] [Abstract][Full Text] [Related]
54. Enhanced protein production by engineered zinc finger proteins.
Reik A; Zhou Y; Collingwood TN; Warfe L; Bartsevich V; Kong Y; Henning KA; Fallentine BK; Zhang L; Zhong X; Jouvenot Y; Jamieson AC; Rebar EJ; Case CC; Korman A; Li XY; Black A; King DJ; Gregory PD
Biotechnol Bioeng; 2007 Aug; 97(5):1180-9. PubMed ID: 17171718
[TBL] [Abstract][Full Text] [Related]
55. Attenuated glutamine synthetase as a selection marker in CHO cells to efficiently isolate highly productive stable cells for the production of antibodies and other biologics.
Lin PC; Chan KF; Kiess IA; Tan J; Shahreel W; Wong SY; Song Z
MAbs; 2019 Jul; 11(5):965-976. PubMed ID: 31043114
[TBL] [Abstract][Full Text] [Related]
56. Reduced alpha4beta1 integrin/VCAM-1 interactions lead to impaired pre-B cell repopulation in alpha 1,6-fucosyltransferase deficient mice.
Li W; Ishihara K; Yokota T; Nakagawa T; Koyama N; Jin J; Mizuno-Horikawa Y; Wang X; Miyoshi E; Taniguchi N; Kondo A
Glycobiology; 2008 Jan; 18(1):114-24. PubMed ID: 17913729
[TBL] [Abstract][Full Text] [Related]
57. Meganuclease-driven targeted integration in CHO-K1 cells for the fast generation of HTS-compatible cell-based assays.
Cabaniols JP; Ouvry C; Lamamy V; Fery I; Craplet ML; Moulharat N; Guenin SP; Bedut S; Nosjean O; Ferry G; Devavry S; Jacqmarcq C; Lebuhotel C; Mathis L; Delenda C; Boutin JA; Duchâteau P; Cogé F; Pâques F
J Biomol Screen; 2010 Sep; 15(8):956-67. PubMed ID: 20625180
[TBL] [Abstract][Full Text] [Related]
58. Proteome analysis of antibody-producing CHO cell lines with different metabolic profiles.
Pascoe DE; Arnott D; Papoutsakis ET; Miller WM; Andersen DC
Biotechnol Bioeng; 2007 Oct; 98(2):391-410. PubMed ID: 17461427
[TBL] [Abstract][Full Text] [Related]
59. EASE vectors for rapid stable expression of recombinant antibodies.
Aldrich TL; Viaje A; Morris AE
Biotechnol Prog; 2003; 19(5):1433-8. PubMed ID: 14524703
[TBL] [Abstract][Full Text] [Related]
60. IRES-mediated Tricistronic vectors for enhancing generation of high monoclonal antibody expressing CHO cell lines.
Ho SC; Bardor M; Feng H; Mariati ; Tong YW; Song Z; Yap MG; Yang Y
J Biotechnol; 2012 Jan; 157(1):130-9. PubMed ID: 22024589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
